Bristol-Myers Squibb develops and markets biopharmaceutical products globally for a wide range of diseases such as oncology, cardiovascular, and covid-19. The company provides various medications, including Revlimid, Eliquis, Opdivo, and Orencia, used for treating multiple myeloma, leukemia, melanoma, and other diseases. Bristol-Myers Squibb distributes its products to pharmacies, hospitals, clinics, and government agencies.